Marion Biomedical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 10.83%
- Profit Growth 8.19%
- Ebitda 9.12%
- Net Worth -69.84%
- Total Assets -57.35%
About Marion Biomedical
Marion Biomedical Private Limited (MBPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 February 2016 (Eight years and 11 months 16 days old ). Its registered office is in Saran, Bihar, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Hamid Hussain, Neyaz Qadri, and Faijan Husain serve as directors at the Company.
Company Details
-
Location
Saran, Bihar, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51109BR2016PTC026070
-
Company No.
026070
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Feb 2016
-
Date of AGM
17 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Patna
Industry
Who are the key members and board of directors at Marion Biomedical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hamid Hussain
|
Managing Director | 23-Feb-2016 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Neyaz Qadri
|
Director | 23-Feb-2016 | Current |
|
Faijan Husain
|
Director | 23-Feb-2016 | Current |
Financial Performance of Marion Biomedical.
Marion Biomedical Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.83% increase. The company also saw a slight improvement in profitability, with a 8.19% increase in profit. The company's net worth observed a substantial decline by a decrease of 69.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marion Biomedical?
Unlock access to Marion Biomedical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Marion Biomedical?
Unlock and access historical data on people associated with Marion Biomedical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marion Biomedical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marion Biomedical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.